35 related articles for article (PubMed ID: 9143326)
1. Thermal inactivation of the reductase domain of cytochrome P450 BM3.
Jamakhandi AP; Jeffus BC; Dass VR; Miller GP
Arch Biochem Biophys; 2005 Jul; 439(2):165-74. PubMed ID: 15950923
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM reveals the architecture of the dimeric cytochrome P450 CYP102A1 enzyme and conformational changes required for redox partner recognition.
Su M; Chakraborty S; Osawa Y; Zhang H
J Biol Chem; 2020 Feb; 295(6):1637-1645. PubMed ID: 31901079
[TBL] [Abstract][Full Text] [Related]
3. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.
Lampe JN
Front Pharmacol; 2017; 8():521. PubMed ID: 28848438
[TBL] [Abstract][Full Text] [Related]
5. Fusion to Hydrophobin HFBI Improves the Catalytic Performance of a Cytochrome P450 System.
Schulz S; Schumacher D; Raszkowski D; Girhard M; Urlacher VB
Front Bioeng Biotechnol; 2016; 4():57. PubMed ID: 27458582
[TBL] [Abstract][Full Text] [Related]
6. Identification of redox partners and development of a novel chimeric bacterial nitric oxide synthase for structure activity analyses.
Holden JK; Lim N; Poulos TL
J Biol Chem; 2014 Oct; 289(42):29437-45. PubMed ID: 25194416
[TBL] [Abstract][Full Text] [Related]
7. Understanding uncoupling in the multiredox centre P450 3A4-BMR model system.
Degregorio D; Sadeghi SJ; Di Nardo G; Gilardi G; Solinas SP
J Biol Inorg Chem; 2011 Jan; 16(1):109-16. PubMed ID: 20857167
[TBL] [Abstract][Full Text] [Related]
8. Structure of a cytochrome P450-redox partner electron-transfer complex.
Sevrioukova IF; Li H; Zhang H; Peterson JA; Poulos TL
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1863-8. PubMed ID: 10051560
[TBL] [Abstract][Full Text] [Related]
9. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid metabolism, conformational change, and electron transfer in cytochrome P-450(BM-3).
Li H; Poulos TL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):141-9. PubMed ID: 10570242
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of the fatty acid hydroxylase activity of cytochrome P450BM-3 utilizing its functional domains.
Sevrioukova I; Truan G; Peterson JA
Arch Biochem Biophys; 1997 Apr; 340(2):231-8. PubMed ID: 9143326
[TBL] [Abstract][Full Text] [Related]
12. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
Sevrioukova I; Truan G; Peterson JA
Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
[TBL] [Abstract][Full Text] [Related]
13. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
14. Probing the structure of the linker connecting the reductase and heme domains of cytochrome P450BM-3 using site-directed mutagenesis.
Govindaraj S; Poulos TL
Protein Sci; 1996 Jul; 5(7):1389-93. PubMed ID: 8819171
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
